CINXE.COM

Disease Treatments | ASGCT - American Society of Gene & Cell Therapy |

<!DOCTYPE html> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <!-- Google Tag Manager --> <script type="text/javascript">(function (w, d, s, l, i) { w[l] = w[l] || []; w[l].push({ 'gtm.start': new Date().getTime(), event: 'gtm.js' }); var f = d.getElementsByTagName(s)[0], j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f); })(window, document, 'script', 'dataLayer', 'GTM-NFW5DS9');</script> <!-- End Google Tag Manager --> <!-- Begin Informz Tracking --> <script type="text/javascript"> //------------------------------------------------------- var z_account = "2632C1D8-6432-4D3A-93D6-08AAECC53F86"; var z_collector = "asgct.informz.net"; var z_cookieDomain = ".asgct.org"; //------------------------------------------------------- (function (e, o, n, r, t, a, s) { e[t] || (e.GlobalSnowplowNamespace = e.GlobalSnowplowNamespace || [], e.GlobalSnowplowNamespace.push(t), e[t] = function () { (e[t].q = e[t].q || []).push(arguments) }, e[t].q = e[t].q || [], a = o.createElement(n), s = o.getElementsByTagName(n)[0], a.async = 1, a.src = r, s.parentNode.insertBefore(a, s)) }(window, document, "script", "https://cdn.informz.net/web_trk/sp.js", "informz_trk")), informz_trk("newTracker", "infz", z_collector + "/web_trk/collector/", { appId: z_account, cookieDomain: z_cookieDomain }), informz_trk("setUserIdFromLocation", "_zs"), informz_trk("enableActivityTracking", 30, 15); informz_trk("trackPageView", null); </script> <!-- End Informz Tracking --> <meta charset="utf-8" /> <meta http-equiv="X-UA-Compatible" content="IE=edge" /> <meta name="viewport" content="width=device-width,user-scalable=no,maximum-scale=1.0,initial-scale=1.0" /> <link href="/BlueKey/pe_assets/build/styles.css" rel="stylesheet" /> <script type="text/javascript" defer="defer" src="https://extend.vimeocdn.com/ga/127349852.js"></script> <meta name="twitter:card" content="summary_large_image" /> <meta name="twitter:site" content="https://twitter.com/ASGCTherapy" <meta name="twitter:creator" content="@ASGCTherapy" <meta name="twitter:title" content="Disease Treatments | ASGCT - American Society of Gene & Cell Therapy" <meta name="twitter:description" content="Gene and cell therapy research shows promise for treating certain rare inherited diseases and forms of cancer." <meta name="twitter:image" content="~c102e26d-0f41-498c-89a2-e878af3b39cc/attachment.aspx" <meta name="description" content="Gene and cell therapy research shows promise for treating certain rare inherited diseases and forms of cancer." /> <meta charset="UTF-8" /> <link href="/App_Themes/Default/Images/favicon.ico" type="image/x-icon" rel="shortcut icon" /> <link href="/App_Themes/Default/Images/favicon.ico" type="image/x-icon" rel="icon" /> <title> Disease Treatments | ASGCT - American Society of Gene &amp; Cell Therapy | </title></head> <body class="LTR IE IE7 ENUS ContentBody"> <!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NFW5DS9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> <form method="post" action="/disease-treatments" id="aspnetForm"> <div class="aspNetHidden"> <input type="hidden" name="__CMSCsrfToken" id="__CMSCsrfToken" value="Q4v+n470nmx875MZ+2R1k6zN0gP+0MABiph4P+yGgCmuSoDCgd6E+1VwdNVM76qImiL3pnTv3Zheeb24SeZWDPjlVDg=" /> <input type="hidden" name="__EVENTTARGET" id="__EVENTTARGET" value="" /> <input type="hidden" name="__EVENTARGUMENT" id="__EVENTARGUMENT" value="" /> <input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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" /> </div> <script type="text/javascript"> //<![CDATA[ var theForm = document.forms['aspnetForm']; if (!theForm) { theForm = document.aspnetForm; } function __doPostBack(eventTarget, eventArgument) { if (!theForm.onsubmit || (theForm.onsubmit() != false)) { theForm.__EVENTTARGET.value = eventTarget; theForm.__EVENTARGUMENT.value = eventArgument; theForm.submit(); } } //]]> </script> <script src="/WebResource.axd?d=UZQNzmZXG1IdUaHxtavOjRvGEvOmz1kvw97PqEaxzBy7Ys-tUotw-RqgdbsvC3g_7cXjehqAdA_N6kbuK73WBAVGdxo1&amp;t=638562384440000000" type="text/javascript"></script> <input type="hidden" name="lng" id="lng" value="en-US" /> <script type="text/javascript"> //<![CDATA[ function PM_Postback(param) { if (window.top.HideScreenLockWarningAndSync) { window.top.HideScreenLockWarningAndSync(1080); } if(window.CMSContentManager) { CMSContentManager.allowSubmit = true; }; __doPostBack('ctl00$CMSPortalManager1$am',param); } function PM_Callback(param, callback, ctx) { if (window.top.HideScreenLockWarningAndSync) { window.top.HideScreenLockWarningAndSync(1080); }if (window.CMSContentManager) { CMSContentManager.storeContentChangedStatus(); };WebForm_DoCallback('ctl00$CMSPortalManager1$am',param,callback,ctx,null,true); } //]]> </script> <script src="/ScriptResource.axd?d=WTJtoz6EJe-loUBJ9stbRxqzgpVp8oo0KdZGkhGfcu6Lr7kb5LeNfx21FKi8mxEL1oDZOLAxiAqERpClgBx-A6lZ0DJ1qKcDZB1NuIbRd8o9S7aG0&amp;t=7c776dc1" type="text/javascript"></script> <script src="/ScriptResource.axd?d=y6KGkkRaceYF_mkApXCXMQ_rMQVX59BlJ-ut-lQDHw88bR5bbS86epdVNwimj01duE6_OophLX4sBTOgb8_5dNLaY2Mx5DHMJj7Rbr4kPMV1-AOS5VF5-QEC8oG-_-aHoWoyqA2&amp;t=7c776dc1" type="text/javascript"></script> <script type="text/javascript"> //<![CDATA[ var CMS = CMS || {}; CMS.Application = { "isDialog": false, "isDebuggingEnabled": false, "applicationUrl": "/", "isRTL": "false", "imagesUrl": "/CMSPages/GetResource.ashx?image=%5bImages.zip%5d%2f" }; //]]> </script> <div class="aspNetHidden"> <input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="5F72FC59" /> <input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="/wEdAAO3hW6IwcSxyW0NeQx6wJSRDMN6QAizBz4KoPbUd79oAZD1NQdfl/cWuar5Vh7dGPSExiVrcgcASPFcNznRvOCZiMlGlg==" /> </div> <script type="text/javascript"> //<![CDATA[ Sys.WebForms.PageRequestManager._initialize('ctl00$manScript', 'aspnetForm', ['tctl00$ctxM',''], [], [], 90, 'ctl00'); //]]> </script> <div id="ctl00_ctxM"> </div> <header class="c-header"> <a href="#content" class="show-on-focus">Skip to main content</a> <div class="c-header-utilities"> <div class="container"> <div class="columns is-vcentered"> <div class="column"> <a href="https://asgct.org" class="is-external">ASGCT.org</a> </div> <div class="column is-half"> <a href="/"> <div class="c-header-images"> <div class="c-header-image"> <img src="/PatientEducation/media/PatientEducation/ASGCT_Web_Horz_Navy.png?ext=.png" alt="" /> </div> <div class="c-header-image"> <img src="/PatientEducation/media/PatientEducation/temp-pe-logo.png?ext=.png" alt="Patient Education Logo" /> </div> </div> </a> </div> <!--/search-results?searchtext=<enteredtext>--> <div class="column"> <div class="c-header-search"> <div class="c-header-search-wrap"> <input name="keyword" type="text" id="searchtext" placeholder="Search" aria-required="false" /> <label for="searchtext" class="is-sr-only">Keyword search</label> <button type="button" data-encode="searchtext" data-path="/search-results" data-query="searchtext"> <span class="is-sr-only">Search</span> <span class="c-search-icon"></span> </button> </div> </div> </div> </div> </div> </div> <div class="c-header-utilities-mobile"> <div class="c-header-images"> <div class="c-header-image"> <a href="https://asgct.org" class="is-external"><img src="/PatientEducation/media/PatientEducation/ASGCT_Web_Horz_Navy.png?ext=.png" alt="" /></a> </div> <div class="c-header-image"> <a href="/"><img src="/PatientEducation/media/PatientEducation/temp-pe-logo.png?ext=.png" alt="Patient Education Logo" /></a> </div> </div> <button class="c-nav-toggle" type="button" aria-controls="c-nav-main" aria-expanded="false" data-togglevisibility="data-togglevisibility"> <p class="is-sr-only">Open Navigation</p> <p class="is-sr-only" aria-hidden="true">Close Navigation</p> <span class="c-nav-toggle-menu"></span> </button> </div> <div id="ctl00_plcMain_bkSiteHeader_headerBanner"> <div class="header-alert"> <div class="container"> <p id="ctl00_plcMain_bkSiteHeader_pBanner"><b><a href="https://patienteducation.asgct.org/newsletter/subscribe-to-the-patient-press">Subscribe today to ASGCT's patient-centered newsletter, The Patient Press!</a></b></p> </div> </div> </div> <nav class="c-nav-main" id="c-nav-main" aria-hidden="true"> <div class="container"> <div class="c-header-search is-hidden-desktop"> <div class="c-header-search-wrap"> <input name="" type="text" id="global-search" placeholder="Search" aria-required="false" /> <label for="global-search" class="is-sr-only">Keyword search</label> <button type="button" data-encode="global-search" data-path="/search-results" data-query="searchtext"> <span class="is-sr-only">Search</span> <span class="c-search-icon"></span> </button> </div> </div> <ul> <li> <a href="/gene-therapy-101">Gene & Cell Therapy 101</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/gene-therapy-101/gene-therapy-basics">Gene Therapy Basics</a> </li> <li> <a href="/gene-therapy-101/cell-therapy-basics">Cell Therapy Basics</a> </li> <li> <a href="/gene-therapy-101/gene-therapy-approaches">Gene Therapy Approaches</a> </li> <li> <a href="/gene-therapy-101/gene-editing">Gene Editing</a> </li> <li> <a href="/gene-therapy-101/clinical-trials">Clinical Trials</a> </li> <li> <a href="/gene-therapy-101/vectors-101">Vectors 101</a> </li> <li> <a href="/gene-therapy-101/glossary">Glossary</a> </li> <li> <a href="/gene-therapy-101/covid19-vaccines">COVID-19</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/disease-treatments">Condition Treatments</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/disease-treatments/fda-approved-cell-gene-therapy-products">FDA-Approved Cell & Gene Therapy Products</a> </li> <li> <a href="/disease-treatments/batten">Batten Disease</a> </li> <li> <a href="/disease-treatments/blood-disorders">Beta Thalassemia & Other Blood Disorders</a> </li> <li> <a href="/disease-treatments/leukodystrophy">CALD and MLD</a> </li> <li> <a href="/disease-treatments/car-t-basics">CAR-T Basics</a> </li> <li> <a href="/disease-treatments/fabry">Fabry Disease</a> </li> <li> <a href="/disease-treatments/gaucher-disease">Gaucher Disease</a> </li> <li> <a href="/disease-treatments/gm1-gangliosidosis">GM1 Gangliosidosis</a> </li> <li> <a href="/disease-treatments/gm2-tay-sachs-sandhoff">Tay-Sachs and Sandhoff Disease</a> </li> <li> <a href="/disease-treatments/hemophilia">Hemophilia</a> </li> <li> <a href="/disease-treatments/huntingtons-disease">Huntington's Disease</a> </li> <li> <a href="/disease-treatments/inherited-retinal-diseases">Inherited Retinal Diseases</a> </li> <li> <a href="/disease-treatments/mps">Mucopolysaccharidoses (MPS)</a> </li> <li> <a href="/disease-treatments/muscular-dystrophy">Muscular Dystrophy</a> </li> <li> <a href="/disease-treatments/pompe-disease">Pompe Disease</a> </li> <li> <a href="/disease-treatments/parkinsons-disease">Parkinson's Disease</a> </li> <li> <a href="/disease-treatments/sickle-cell-disease">Sickle Cell Disease</a> </li> <li> <a href="/disease-treatments/sma">Spinal Muscular Atrophy</a> </li> <li> <a href="/disease-treatments/wilson-disease">Wilson Disease</a> </li> <li> <a href="/disease-treatments/xlmtm">X-Linked Myotubular Myopathy</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/patient-journey">Patient Journey</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/patient-journey/identifying-a-genetic-disease">Identifying a Genetic Disease</a> </li> <li> <a href="/patient-journey/next-steps-with-a-diagnosis">Next Steps With a Diagnosis</a> </li> <li> <a href="/patient-journey/patient-focused-policy-positions">Patient-Focused Policy Positions</a> </li> <li> <a href="/patient-journey/stimulating-research">Stimulating Research</a> </li> <li> <a href="/patient-journey/considering-a-clinical-trial">Considering a Clinical Trial</a> </li> <li> <a href="/patient-journey/ethical-issues-germline-gene-editing">Ethical Issues: Germline Gene Editing</a> </li> <li> <a href="/patient-journey/ethical-issues-illegitimate-clinical-trials">Ethical Issues: Unproven Stem Cell Products</a> </li> <li> <a href="/patient-journey/gene-therapy-centers">Gene Therapy Centers</a> </li> <li> <a href="/patient-journey/clinical-trials-finder">Clinical Trials Finder</a> </li> <li> <a href="/patient-journey/on-demand">On Demand Webinars</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/newsletter">Newsletter</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/newsletter/subscribe-to-the-patient-press">Subscribe to The Patient Press</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/quick-takes">Quick Takes</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/quick-takes/focused-ultrasound-in-cell-and-gene-therapies">Focused Ultrasound in CGTs</a> </li> <li> <a href="/quick-takes/access-to-approved-cell-and-gene-therapies">Access to Approved CGTs</a> </li> <li> <a href="/quick-takes/informed-consent">Informed Consent</a> </li> <li> <a href="/quick-takes/state-of-the-field-cgt-highlights-and-approvals-20">State of the Field: CGT Highlights and Approvals of 2023</a> </li> <li> <a href="/quick-takes/genetic-testing-and-clinical-trial-eligibility">Genetic Testing and Clinical Trial Eligibility</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/events">Events</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/events/empowering-patients-2025-a-cell-and-gene-therapies">Empowering Patients 2025: A Cell and Gene Therapies Summit</a> </li> <li> <a href="/events/annual-meeting-patient-advocate-offerings">Annual Meeting-Patient Advocate Offerings</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/about-asgct">About</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/about-asgct/overview">Overview</a> </li> <li> <a href="/about-asgct/about-asgct">About ASGCT</a> </li> <li> <a href="/about-asgct/news">ASGCT News</a> </li> <li> <a href="/about-asgct/privacy-policy">Privacy Policy</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/support">Support</a> </li> </ul> <a href="asgct.org" class="px-1 is-external is-hidden-desktop">ASGCT.org</a> </div> </nav> <div class="c-banner" style="background: url('/getattachment/Disease-Treatments/Batten_Disease_1280x720_1_00000.png.aspx') 50%/cover no-repeat;"> <div class="c-banner-content container"> <h1>Condition Treatments</h1> <hr /> <p class="is-large">Gene and cell therapy research shows promise for treating certain rare inherited diseases and forms of cancer.</p> </div> </div> </header> <main class="c-main" id="content"> <section class="section wrap"> <div class="container"> <div class="is-flex-center tile is-ancestor py-5"> <div class="tile is-6 is-parent"> <a href="/Disease-Treatments/Batten" class="tile is-child c-tile-link-alternate"> <h2>Batten Disease</h2><p>Different forms of the disease being researched for potential treatments聽include CLN1, 2, 3, 5, 6, 7, and 8.</p> </a> </div> <div class="tile is-6 is-parent"> <a href="/disease-treatments/fabry" class="tile is-child c-tile-link-alternate"> <h2>Fabry Disease</h2><p>Gene therapy approaches target a faulty GLA gene.</p> </a> </div> </div> </div> </section> <section class="section wrap pattern pb-x1" style="background: url('/PatientEducation/media/PatientEducation/square-background.png') repeat;"> <div class="container pt-6"> <div class="columns"> <div class="column is-three-fifths is-offset-one-fifth is-centered"> <h2>Disease Resources</h2><p>Visit these pages for information on specific diseases and how gene therapy can help.</p> </div> </div> <div class="columns"> <div class="column is-10 is-offset-1"> <div class="c-tile-wrap mb-5"> <div class="c-tile"> <a href="/disease-treatments/blood-disorders" class="c-tile-link"> <h3>Blood Disorders</h3> <hr /> <p>Take a closer look at beta thalassemia and Fanconi anemia.</p> </a> </div> <div class="c-tile"> <a href="/disease-treatments/car-t-basics" class="c-tile-link"> <h3>CAR-T Basics</h3> <hr /> <p>Learn about approved treatments for blood cancers, such as leukemia and lymphoma.</p> </a> </div> <div class="c-tile"> <a href="https://patienteducation.asgct.org/disease-treatments/fabry" class="c-tile-link"> <h3>Fabry Disease</h3> <hr /> <p>Learn how <em>in vivo</em> and <em>ex vivo</em> gene therapy approaches can be used to treat Fabry disease by delivering a working GLA gene into cells.</p> </a> </div> <div class="c-tile"> <a href="https://patienteducation.asgct.org/disease-treatments/gaucher-disease" class="c-tile-link"> <h3>Gaucher Disease</h3> <hr /> <p>Learn about this rare genetic disorder that causes the harmful buildup of glycolipids throughout the body and how gene therapy may be able to address its symptoms.</p> </a> </div> <div class="c-tile"> <a href="https://patienteducation.asgct.org/disease-treatments/gm1-gangliosidosis" class="c-tile-link"> <h3>GM1 Gangliosidosis </h3> <hr /> <p>Gene therapy for GM1 aims to be a one-time treatment that delivers a working copy of the&nbsp;<em>GLB1</em>&nbsp;gene into cells using a viral vector.</p> </a> </div> <div class="c-tile"> <a href="/disease-treatments/hemophilia" class="c-tile-link"> <h3>Hemophilia</h3> <hr /> <p>Gene therapy has the potential to increase&nbsp;clotting factors to treat hemophilia A and B.</p> </a> </div> <div class="c-tile"> <a href="/disease-treatments/huntingtons-disease" class="c-tile-link"> <h3>Huntington's Disease</h3> <hr /> <p>A genetic disorder caused by a breakdown of nerve cells in the brain.</p> </a> </div> <div class="c-tile"> <a href="/disease-treatments/inherited-retinal-diseases" class="c-tile-link"> <h3>Inherited Retinal Diseases</h3> <hr /> <p>A closer look at gene therapy for Leber congenital amaurosis (LCA), retinitis pigmentosa, choroideremia, Stargardt&rsquo;s disease, and achromatopsia.</p> </a> </div> <div class="c-tile"> <a href="/disease-treatments/leukodystrophy" class="c-tile-link"> <h3>Leukodystrophies</h3> <hr /> <p>These are a set of rare genetic disorders including cerebral adrenoleukodystrophy (CALD), and metachromatic leukodystrophy (MLD).</p> </a> </div> <div class="c-tile"> <a href="/disease-treatments/mps" class="c-tile-link"> <h3>MPS</h3> <hr /> <p>Learn more about gene therapy research for mucopolysaccharidoses (MPS) types I, II, III and VI, also referred to as Hurler syndrome, Hunter syndrome, and Sanfilippo syndrome.&nbsp;</p> </a> </div> <div class="c-tile"> <a href="/disease-treatments/muscular-dystrophy" class="c-tile-link"> <h3>Muscular Dystrophy</h3> <hr /> <p>Gene therapy has the potential to treat Duchenne and certain subtypes of limb-girdle muscular dystrophy.</p> </a> </div> <div class="c-tile"> <a href="/disease-treatments/parkinsons-disease" class="c-tile-link"> <h3>Parkinson's Disease</h3> <hr /> <p>Learn about the potential to treat a degenerative neurological disease that over time causes the death of brain cells.</p> </a> </div> <div class="c-tile"> <a href="/disease-treatments/condition-detail" class="c-tile-link"> <h3>Pompe Disease</h3> <hr /> <p>This rare genetic glycogen storage disease is caused by a faulty GAA gene.</p> </a> </div> <div class="c-tile"> <a href="/disease-treatments/sickle-cell-disease" class="c-tile-link"> <h3>Sickle Cell Disease</h3> <hr /> <p>Learn how gene therapy and gene editing may address the genetic cause of sickle cell disease.</p> </a> </div> <div class="c-tile"> <a href="/disease-treatments/sma" class="c-tile-link"> <h3>Spinal Muscular Atrophy</h3> <hr /> <p>Learn more about the FDA-approved gene therapy Zolgensma that targets&nbsp;the SMN1 gene.</p> </a> </div> <div class="c-tile"> <a href="https://patienteducation.asgct.org/disease-treatments/wilson-disease" class="c-tile-link"> <h3>Wilson Disease</h3> <hr /> <p>Gene therapy may target the cause of this disease, which&nbsp;causes excess copper to be stored in the body.</p> </a> </div> <div class="c-tile"> <a href="/disease-treatments/xlmtm" class="c-tile-link"> <h3>X-Linked Myotubular Myopathy</h3> <hr /> <p>Also known as XLMTM, this&nbsp;rare genetic disorder primarily causes muscle weakness caused by a faulty MTM1 gene.</p> </a> </div> </div> </div> </div> </div> </section> </main> <footer class="c-footer"> <div class="c-footer-primary"> <section class="section"> <div class="container"> <div class="columns"> <div class="column c-footer-section"> <p><img alt="" src="/PatientEducation/media/PatientEducation/logo_white.png" /></p> <p>20800 Swenson Dr., Suite 300<br /> Waukesha, WI 53186</p> </div> <div class="column is-two-fifths c-footer-section"> <ul class="c-utility-list"> <li><a href="#">Gene Therapy 101</a></li> <li><a href="#">Disease Treatments</a></li> <li><a href="#">Clinical Trials</a></li> <li><a href="/patient-journey">Patient Journey</a></li> <li><a href="/about-asgct">About</a></li> <li><a href="/support">Support</a></li> <li><a href="https://asgct.org/about/privacy-policy" target="_blank">Privacy Policy</a></li> </ul> </div> <div class="column c-footer-section"> <h3 class="mb-3">Connect with ASGCT</h3> <p class="mb-0"><span>Phone: 414</span>.278.1341</p> <p><a href="mailto:info@asgct.org">info@asgct.org</a></p> <p> <div class="c-social"> <ul class="c-social-list"> <li class="c-social-item"><a href="https://twitter.com/ASGCTherapy" target="_blank" class="c-social-link twitter"><span class="is-sr-only">Twitter</span></a></li> <li class="c-social-item"><a href="https://www.facebook.com/ASGCTherapy" target="_blank" class="c-social-link facebook"><span class="is-sr-only">Facebook</span></a></li> <li class="c-social-item"><a href="https://www.instagram.com/asgctherapy" target="_blank" class="c-social-link instagram"><span class="is-sr-only">Instagram</span></a></li> <li class="c-social-item"><a href="https://www.linkedin.com/company/asgct" target="_blank" class="c-social-link linkedin"><span class="is-sr-only">LinkedIn</span></a></li> <li class="c-social-item"><a href="https://www.youtube.com/user/ASGCT" target="_blank" class="c-social-link youtube"><span class="is-sr-only">YouTube</span></a></li> </ul> </div> </p> </div> </div> </div> </section> </div> <div class="c-footer-secondary"> <section class="section py-4"> <div class="container"> <div class="columns"> <div class="column"> <p class="is-small">&copy; 2024&nbsp;All rights reserved. American Society of Gene &amp; Cell Therapy.</p> <p class="is-tiny">Web design by <a href="https://www.reasononeinc.com/kentico" target="_blank">Reason One</a>. Powered by <a href="http://www.kentico.com" target="_blank">Kentico</a>.</p> </div> </div> </div> </section> </div> </footer> <div class="CookieConsent"> <span id="ctl00_cookieLawQ_lblText" class="ConsentText">This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.</span> <span class="ConsentButtons"> <input type="submit" name="ctl00$cookieLawQ$btnAllowSpecific" value="OPT OUT" id="ctl00_cookieLawQ_btnAllowSpecific" class="ConsentButton btn btn-default" /> <input type="submit" name="ctl00$cookieLawQ$btnAllowAll" value="ACCEPT" id="ctl00_cookieLawQ_btnAllowAll" class="ConsentButton btn btn-default" /> </span> </div> <script src="/BlueKey/pe_assets/build/main.js" type="text/javascript"></script> <script type="text/javascript"> //<![CDATA[ var callBackFrameUrl='/WebResource.axd?d=nNME_ObE2oIDm535eYM9xWmIMy-HXBVdo54Ly6sA5tAYPS1aA-gFDzodlP9ijTBRgmjStONrH4-ISuRTp7slHiYkACw1&t=638562384440000000'; WebForm_InitCallback();//]]> </script> </form> </body> </html>

Pages: 1 2 3 4 5 6 7 8 9 10